Phytoestrogens in Human Pregnancy by Jarrell, John et al.
Hindawi Publishing Corporation
Obstetrics and Gynecology International




John Jarrell,1 Warren G. Foster,2 andDavidW. Kinniburgh3
1Department of Obstetrics and Gynecology, University of Calgary, 1403 29 NW Street, Calgary, AB, Canada T2N 2T9
2Reproductive Biology Division, Department of Obstetrics and Gynecology, McMaster University, Hamilton,
ON, Canada L8N 3Z5
3Alberta Centre for Toxicology, University of Calgary, Calgary, AB, Canada T2N 2T9
Correspondence should be addressed to John Jarrell, john.jarrell@albertahealthservices.ca
Received 1 July 2011; Revised 24 February 2012; Accepted 9 March 2012
Academic Editor: Everett Magann
Copyright © 2012 John Jarrell et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. The hormonal milieu associated with pregnancy has become a focus of interest owing to potential links with the
developmental origins of health and disease. Phytoestrogens are hormonally active plant-derived chemicals that may have an
impact on human reproductive processes. However, developmental exposure to phytoestrogens has not been well characterized
and thus our objective was to quantify phytoestrogen exposure during pregnancy and lactation. Methods. Women in the second
trimester of pregnancy entered the study during counseling for prenatal genetic information. Women who had an indication
for a genetic amniocentesis on the basis of late maternal age were approached for inclusion. They completed an environmental
questionnaire; a sample of amniotic ﬂuid was collected for karyotype, blood was collected from women during pregnancy and
at birth, from the umbilical cord and breast milk. Samples were tested for the presence of daidzein and genistein by GC Mass
Spectroscopy. Findings. Phytoestrogens are commonly found in pregnant women’s serum and amniotic ﬂuid during pregnancy.
There is a sex diﬀerence in the concentrations with higher levels in amniotic ﬂuid containing female fetuses. This diﬀerence was
not present in maternal serum. Soy ingestion increases amniotic ﬂuid phytoestrogen concentrations in female and male fetuses.
The presence and concentrations of phytoestrogens did not diﬀer in relation to common pregnancy complications or preexisting
infertility.
1.Introduction
Phytoestrogens are naturally occurring polycyclic phenols
that are isolated from certain plants [1]. They are of interest
due to their weak estrogenic functions [2]. They are most
commonly found in isoﬂavones and lignans [3]. The most
common source of isoﬂavones is soy-based products either
directly or indirectly ingested in the diet [4]. Daidzein and
genistein are among the most frequently isolated isoﬂavones
[5].
Importantly, there is considerable variation in the con-
centration of the compounds owing to diﬀerent rates of
absorption and metabolism [6]. The phytoestrogens are
ingested in their beta-glycosidic state which are hydrolyzed
in the intestine, absorbed and then undergo glucuronidation
intheintestinalwallandtheliver[6].Itistheglucuronidated
compounds that circulate and are measured in the blood and
urine [7, 8]. Excretion is rapid, occurring in approximately
24 hours. There have been few studies of human pregnancy
kinetics, but the phytoestrogens daidzein and genistein have
been found in amniotic ﬂuid and transplacental passage of
genisteinhasbeendocumentedinvitroinhumanandinvivo
in rat placentae [9–12].
There are concerns that these chemicals may, alone or
in combination with other chemicals, function as endocrine
disruptors, with potentially adverse eﬀects on male repro-
ductive function although there are not suﬃcient data avail-
abletoconﬁrmtheseconcerns[13].Onemeta-analysisofﬁf-
teen placebo-controlled trials with baseline and intervention
levels of testosterone, sex hormone binding globulin, free
testosterone, and free androgen index failed to demonstrate
that ingestion of soy foods or phytoestrogens altered testos-
terone bioavailability. Studies of human exposure during
pregnancy have been limited in number [14]. Therefore
this study was designed to evaluate the concentrations and
correlations of daidzein and genistein in the amniotic ﬂuid,2 Obstetrics and Gynecology International
Table 1: Clinical variables.
N Minimum Maximum Mean Standard
deviation
Age 238 35 48 39.03 2.29
BMI 238 16.47 42.77 24.08 7.11
Gravida 319 1.00 10 2.78 1.52
Parity 317 0 6 0.94 0.93
Term 316 0 6 0.89 0.94
Preterm 316 0 1 0.04 0.21
Stillbirth 318 0 1 0.00 0.06
Spont Ab 316 0 5 0.54 0.89
Therapy Ab 315 0 3 0.30 0.60
Smokers 238 0 1 0.08 0.27
Number of
Cigarettes 238 0 20 0.60 2.52
Spont Ab: Spontaneous abortion.
maternal serum during pregnancy, at birth, the umbilical
cord levels, and breast milk concentration in relation to
important clinical variables and pregnancy outcomes. A
parallel study from this cohort of women on the concentra-
tions of chlorinated organic chemical exposure in pregnancy
has been reported [15].
2. Methods
Pregnant women attending a prenatal counseling session at
Foothills Hospital in Calgary, Alberta, were approached to
participate in this project. Approval was obtained from the
University of Calgary Ethics committee. Three hundred and
twenty-three women were enrolled after their eligibility was
determined. They were seeking counseling for age-related
genetic counseling and all women were at least 35 years of
age. The women were approached during an educational
presentation for genetic testing. Although the project was
very popular, the total number attending the sessions is not
known.
Of those agreeing to participate, two hundred and thirty-
eight completed an environmental questionnaire. Amniotic-
ﬂuid was collected for testing from three hundred and
twenty-three women. Blood was collected from two hundred
and nine women during the second trimester of pregnancy,
one hundred and ﬁve women at the time of delivery, and
ninety seven from cord samples at delivery, and forty-seven
samples of breast milk were collected. The peripheral blood
was collected in red topped tubes in a volume of 10–20mL,
allowed to clot at 4◦C and centrifuged.
Clinical information was collected from three Calgary
hospitals and three hospitals outside the Calgary Health
Region. The samples were collected by the regional laborato-
ry in specially prepared glass tubes, centrifuged and trans-
ferred to the Centre for Toxicology, University of Calgary for
analysis.
Table 2:Phytoestrogenconcentrationoverthecourseofpregnancy.






daidzein 300 0.60 0.08 1.41
Amniotic ﬂuid
genistein 300 0.77 0.10 1.78
Serum during




215 5.18 1.84 27.02
Serum at birth
daidzein 97 1.21 0.55 5.45
Serum at birth
genistein 100 1.48 0.84 8.40
Cord serum
daidzein 75 2.30 0.81 7.02
Cord serum
genistein 85 2.68 1.07 9.87
Breast milk
daidzein 90 0.25 0.11 1.03
Breast milk
genistein 84 0.61 0.24 2.20
Daidzein and genistein were measured by Gas Chro-
matography Mass Spectrometry (GSMS) using an Hewlett-
Packard 6890 Gas Chromatograph equipped with a HP 5973
Mass Spectral (MS) Detector and a Hewlett-Packard Cap-
illary Column HP-5MS (cross-linked 5% PH ME Siloxane)
(30m × 0.25mm i.d., ﬁlm thickness: 0.25µm) (Agilent
Technologies, CA, USA). Breast milk was vortexed for 5
minutes before being prepared for extraction and serum
and amniotic ﬂuid were analyzed without pretreatment.
Amniotic ﬂuid was not diluted with Type I water (Milli-Q
Synthesis,MilliporeLtd.,ON,Canada)andwasnotextracted
with solid phase extraction prior to liquid/liquid extraction.
A 1mL sample aliquot was spiked with internal standards
and buﬀered with the 0.5M acetic buﬀer to a pH of 5.2.
DaidzeinandgenisteinwereobtainedfromTorontoResearch
Chemicals Inc., Ontario, Canada. Daidzein-d3 was obtained
from Radian International, TX, USA, and Genistein-d3 was
obtained from Cambridge Isotope Laboratories, Inc., MA,
USA. The sample was hydrolyzed for 3 hours at 60◦Cw i t h
the Type H-5 Helix pomatia enzyme (Sigma-Aldrich, MO,
USA). After hydrolysis, sample was diluted with Type I water
(1:1 ratio for serum and 1:4 for breast milk) and sonicated
for 30 minutes (Bransonic 2210, Branson Ultrasonics, CT,
USA). The sample was extracted using solid phase extraction
with a conditioned C18 cartridge and eluted with diethyl
ether. The eluent was then dried down and reconstituted
with water and then further cleaned up with hexane. The
aqueous sample was then extracted with diethyl ether. The
organic layer was dried with anhydrous sodium sulfate and
then evaporated down to dryness under nitrogen gas atObstetrics and Gynecology International 3
Table 3: Phytoestrogen concentration during pregnancy by sex of fetus.
Phytoestrogen concentration during pregnancy by sex of fetus
Sex N Mean Standard deviation Standard error mean
Amniotic ﬂuid daidzein Male 152 0.41 0.82 0.07
Female 136 0.85 1.88 0.16
Amniotic ﬂuid genistein Male 152 0.55 1.25 0.10
Female 136 1.04 2.27 0.19
Serum during pregnancy daidzein Male 118 2.77 13.36 1.23
Female 94 3.08 12.71 1.31
Serum during Pregnancy genistein Male 118 5.16 27.23 2.51
Female 94 5.36 27.33 2.82
Serum at birth daidzein Male 55 0.75 1.69 0.23
Female 42 1.82 8.07 1.25
Serum at birth genistein Male 56 0.68 1.56 0.21
Female 43 2.55 12.69 1.94
Cord serum daidzein Male 37 2.66 8.28 1.36
Female 36 2.02 5.77 0.96
Cord serum genistein Male 45 3.27 11.64 1.73
Female 38 2.08 7.70 1.25
Breast milk daidzein Male 43 0.36 1.41 0.21
Female 46 0.16 0.49 0.07
Breast milk genistein Male 42 0.87 2.86 0.44
Female 42 0.36 1.21 0.19
40◦C. The sample was then derivatized with N-Methyl-
N-[trimethylsilyl]-triﬂuoroacetamide (MSTFA) (Sigma M-
7891) in Dithioerythritol (Sigma D-8255), (Sigma-Aldrich,
MO, USA) at 70◦C for 30 minutes, and 1uL of the extract
was injected on the GC/MS. The LOQ for the method was
0.5ng/mL for both diadzein and genistein.
As the results of the concentrations were skewed, analysis
was done using nonparametric statistics. Nondetectable
concentrationsweretreatedaszero.Forcomparisonbetween
compartments, the Wilcoxon signed ranks test was used.
For correlation analysis, Spearman’s test was used. Normally
distributed data were compared using t-Test. A P<0.05 was
considered statistically signiﬁcant.
3. Results
The demographics and reproductive histories of the women
are summarized in Table 1. During the previous year 15.1%
of the women reported that they were smokers; 8% contin-
ued to smoke during this pregnancy with an average of less
than 20 cigarettes per day.
Sixty-six women reported being on a speciﬁc diet, most
commonly weight reduction, and eighty-ﬁve women report-
ed a signiﬁcant weight loss of an average of 7.3pounds. A
subgroup of one hundred and six women provided detailed
information on soy supplementation in their diet.
Of the pregnancies under review there were 291 births
in which the following complications occurred: pregnancy-
induced hypertension of 8.2%, premature labor of 3.4%,
gestational diabetes of 5.2%, low birth weight of 4.8%,
and Caesarian section rate of 27%. The mean birthweight
was 3404 ± 533 (SD) g. There was no diﬀerence in
birthweight between male and female infants. The sex ratio
(male/female) was 1.13. The frequency of women reporting
prior infertility was 12% in this study. Genetic analysis
determinedthatthereweretwocasesofKlinefeltersyndrome
and 2 cases of trisomy that went on to deliver.
Of the 323 women who had sampling of the amniotic
ﬂuid, 300 had testing for phytoestrogens, and of these sam-
ples,185(62%)containeddetectabledaidzeinand183(61%)
detectable genistein. The concentrations of the phytoestro-
gens among all samples and the concentrations in male and
female pregnancies are presented in Tables 2 and 3.T h e
serum concentrations were higher in maternal serum during
pregnancy than those in amniotic ﬂuid. There were no
diﬀerences in the concentrations of daidzein and genistein in
serum during pregnancy compared to serum at birth. There
were signiﬁcant correlations between the amniotic levels of
daidzein with both daidzein and genistein and maternal
serum during pregnancy and at birth and cord serum with
the exception of serum at birth genistein levels. There were
signiﬁcant correlations of amniotic ﬂuid genistein with both
daidzein and genistein in all compartments (Table 4). The
degree of correlation was greater for genistein than that
for daidzein. Breast milk samples of daidzein correlated
with amniotic ﬂuid genistein while breast milk samples
of genistein correlated with amniotic ﬂuid daidzein levels
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99: refers to women without soy diet information
Figure 1:TheamnioticﬂuidlevelsofDaidzein(ng/mL)bysoydiet.










































99: refers to women without soy diet information
Figure 2: The amniotic ﬂuid levels of Genistein (ng/mL) by soy
diet.
Notably there were signiﬁcantly higher concentrations
in the amniotic ﬂuid of pregnancies with female fetuses
compared to amniotic ﬂuid of pregnancies with male preg-
nancies. Amniotic ﬂuid daidzein concentrations from male
pregnancies were 48% of the concentrations from female
pregnancies while the amniotic ﬂuid genistein concentra-
tions from male pregnancies were 54% of the concentrations
from female pregnancies P<0.05. There were no sex-related
diﬀerences in serum during pregnancy, at birth, cord serum,
or breast milk. Although the mean concentrations of cord
daidzein and genistein were higher than maternal blood at
birth, these diﬀerences were not statistically signiﬁcant.
Among women reporting their soy intake, there was
an increase in the amniotic ﬂuid levels of daidzein and
genistein (Figures 1 and 2). There was no diﬀerence in
the frequencies of intake between male and female fetuses
(Table 5). However, women who reported the use of soy
products were found to have higher concentrations of
daidzein and genistein in the amniotic ﬂuid in pregnancies
with a female fetus than with a male fetus (Figures 3 and 4).
The concentrations of daidzein and genistein did not
diﬀer when the levels were compared among women with
Table 5: The relationship of soy in the diet to the sex of the fetus.
Frequency Male Female Total
Soy in diet
n e v e r 1 271 9
monthly 28 20 48
weekly 10 11 21
daily 5 9 14
No response 69 60 129
Total 124 107 231
Amniotic ﬂuid levels of daidzein (ng/mL)




























































































0: male, 1: Female
1 0
Figure 3: The amniotic ﬂuid levels of Daidzein (ng/mL) by soy diet
and sex of fetus.
complications of pregnancy including premature labor,
pregnancy-induced hypertension, gestational diabetes, low
birth weight, or Caesarian section. There were no diﬀerences
in the amniotic ﬂuid levels of phytoestrogens among women
reporting prior infertility compared to those who did not
report infertility. There was no increase in the rates of infer-
tility among women who ingested higher concentrations of
soy products.
4. Discussion
The results of these investigations indicate that the phytoe-
strogens are commonly identiﬁed in the amniotic ﬂuid and
blood of women and fetuses during pregnancy as previously
reported [16]. The concentrations are higher in the maternal
serum than those in the amniotic ﬂuid although there were
no signiﬁcant diﬀerences between amniotic ﬂuid and serum
at birth, cord serum, or breast milk. The signiﬁcant corre-
lations indicate that measures of cord blood phytoestrogens
can provide a reasonable estimate of the levels that were
present in amniotic ﬂuid, earlier in pregnancy.
One signiﬁcant ﬁnding not previously reported was the
diﬀerencenotedbetweenmaleandfemalefetuseswithsignif-
icantly higher concentrations among the female fetuses. No
immediate explanation for this is apparent. The birthweights6 Obstetrics and Gynecology International
Amniotic ﬂuid levels of genistein (ng/mL)





























































































0: male, 1: Female
1 0
Figure 4:TheamnioticﬂuidlevelsofGenistein(ng/mL)bysoydiet
and sex of fetus.
of the male and female infants were similar suggesting that
fetal size would not be an explanation. The sex diﬀerences
in amniotic ﬂuid daidzein and genistein suggest that there
may be a diﬀerential metabolic handling of these chemicals
during fetal life. Previous studies of adult human urine
levels of phytoestrogens have not demonstrated sex-related
diﬀerences however [17]. There were diﬀerences in intestinal
metabolism of microﬂora noted in other human studies in
response to soy-augmented diet [18].
Soy levels of ingestion were assessed in 102/231 women,
and among these women, there was a higher level of daidzein
and genistein in the amniotic ﬂuid. This did not appear to
be the explanation for sex diﬀerences as the frequency of the
soy ingestion patterns did not diﬀer by sex. The data suggest
that dietary soy concentrations should be considered in the
analysis of amniotic ﬂuid concentrations of phytoestrogens.
This ﬁnding of a sex diﬀerence should be conﬁrmed, as
early exposure to these chemicals has been suggested as an
important area of research due to the possibility that these
chemicals can act alone or in combination with other chemi-
calsas endocrine disruptors [19].Safetyofthese chemicalsin
relation to androgen metabolism in males has been reported
[20].
There was no diﬀerence in the concentrations between
the fetus and mother at birth, consistent with previous stud-
ies of the transplacental passage of the chemicals [9, 21].
The strengths of the study are based on it being a
prospective study of a large sample size of pregnant women
employing direct measurements of exposure with state-of-
the-art techniques. The study provides information that
demonstrates a dose relationship of phytoestrogens to soy
consumption.
The limitations are based on the sample size being too
s m a l lt oe v a l u a t ee x p o s u r ew i t hs p e c i ﬁ ca d v e r s eh e a l t h
outcomes, and the study population is not representative of
thegeneralpopulationofpregnantwomen.Also,thesamples
of cord blood and breast milk are available for only a small
segment of the population. In relation to the soy ingestion,
there are no data to indicate the type of soy or the last time
of ingestion.
In summary, we have demonstrated that pregnant wom-
enofadvancedmaternalagehaveexposuretophytoestrogens
which can be measured in the amniotic ﬂuid and umbilical
cord blood demonstrating fetal exposure. Moreover, when
soy consumption was considered, there was a dose response
relationship for phytoestrogens in the amniotic ﬂuid. Finally,
concentrations of daidzein were signiﬁcantly higher in the
amniotic ﬂuid of female versus male fetuses suggesting
potential sex diﬀerences in metabolic capacity of the fetus.
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